USEReady Joins OpenAI Partner Network to Accelerate Enterprise AI Adoption

Combining production-grade GenAI and Agentic AI expertise with OpenAI technology to help enterprises move from AI experimentation to measurable business impact. [PR.com]

Posted on: 23 September 2026 | 3:54 pm

ALS TDI to Convene ALS Research, Industry, and Community Leaders at 2026 Summit and White Coat Affair Gala

This October, two Boston events will bring people together to share research updates, build connections, and accelerate progress for people with ALS. [PR.com]

Posted on: 23 September 2026 | 7:40 am

SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease

SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. [PR.com]

Posted on: 18 September 2026 | 2:00 am

Rob Merrill Named CEO of TFives, Life Sciences AI Compliance

TFives appoints 25-year healthcare regulatory veteran as CEO to lead enterprise adoption of compliance-ready AI governance for the Life Sciences industry. [PR.com]

Posted on: 17 September 2026 | 8:58 pm

Microvascular Therapeutics Appoints George Kokke to Board of Directors

Veteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience. [PR.com]

Posted on: 17 September 2026 | 7:00 am

Beyond the Scale: Emerge Weight Loss Expands GLP-1 Telehealth Care to Support Women Living With PCOS and Endometriosis

As emerging research illuminates tirzepatide's metabolic and anti-inflammatory effects, Emerge extends compassionate, medically supervised weight loss care from board-certified providers to women whose health needs reach far beyond a number on the scale. [PR.com]

Posted on: 2 September 2026 | 8:04 am

Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program

Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. [PR.com]

Posted on: 29 August 2026 | 2:00 am

BIX 2026 to Spotlight the Future of Stem Cell and Global Biopharma M&A

BIX 2026 unveils keynotes on stem cell advances for nervous system diseases and global biopharma M&A trends, bringing together biotech leaders, investors, and researchers to drive collaboration and innovation. [PR.com]

Posted on: 21 August 2026 | 11:12 am

New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors

Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. [PR.com]

Posted on: 12 August 2026 | 8:00 am

Lobbie Continues Building the Modern Clinic Platform with Enhanced Patient Billing

Today’s clinics can strengthen cash flow and streamline operations building more sustainable businesses by unifying patient acquisition, intake, clinical workflows, billing, memberships, and payments in one integrated platform. [PR.com]

Posted on: 6 August 2026 | 2:00 am

Microvascular Therapeutics Highlights the Future of Ultrasound Theranostics in Comprehensive Wiley Review

Microvascular Therapeutics, Inc. (MVT) today announced publication of a comprehensive review in Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (WIREs Nanomedicine and Nanobiotechnology), a leading peer-reviewed journal with a 2025 Journal Impact Factor of 8.6, entitled, "Development of Ultrasound Microbubbles and Phase Shift Microbubbles in Theranostics." The review, authored by Emmanuelle [PR.com]

Posted on: 28 July 2026 | 6:40 am

Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe

Slimshot® recognized in Medical Devices & Technology Concept category; product selected for display at Red Dot Design Museum in Singapore. [PR.com]

Posted on: 14 July 2026 | 12:32 pm

Validation Management Solutions Expands Leadership Team with the Appointment of Remoun Amin as Partner

Validation Management Solutions (VMS) has appointed Remoun Amin as Partner, marking an important milestone in the company's growth. With more than two decades of life sciences experience, Amin strengthens VMS's ability to deliver expert CQV, calibration, and temperature mapping services while advancing its vision to help clients build assurance that scales with them. [PR.com]

Posted on: 9 July 2026 | 2:00 am

GW Health Announces Strategic AI Partnership to Expand Communications Capabilities

Announced at the Cannes Lions Festival, the collaboration pairs senior communications expertise with innovative scientific storytelling. [PR.com]

Posted on: 22 June 2026 | 7:00 am

DSV Launches Direct Luxembourg–indianapolis Pharma Air Route to Improve Temperature-Controlled Deliveries

DSV launches the latest expansion of its Air ThermoDirect solution through Indianapolis International Airport, strategically strengthening pharmaceutical supply chains with enhanced cold-chain connectivity from one of the United States’ fastest-growing life sciences and healthcare logistics hubs. By minimizing time spent in uncontrolled environments and removing the complexity of active containers, Air ThermoDirect [PR.com]

Posted on: 9 June 2026 | 8:00 am

Alera Bio Appoints David McCullough as Chief Executive Officer

Alera Bio announced the appointment of David McCullough as Chief Executive Officer. An experienced biotechnology executive, McCullough will lead corporate strategy, financing, organizational development, and execution of the company’s clinical and regulatory roadmap. He will oversee advancement of AB-101, Alera’s novel therapy for MCT-8 deficiency, as the company works to bring new hope to patients and families [PR.com]

Posted on: 4 June 2026 | 2:00 am

SPARK Industries Announces New MRI Signal Analysis Platform for Neurological Disease and Cancer Research

SPARK Industries announced advancements in its patent-pending MRI signal-analysis platform designed to detect previously unresolved neurological and structural signatures within raw MRI data. Internal validation across 1,000+ clinical MRI cases involving TBI, Alzheimer’s, Parkinson’s, and prostate cancer demonstrated consistent signal relationships associated with known disease states. SPARK is now pursuing blinded [PR.com]

Posted on: 27 May 2026 | 7:04 am

HourScript Launches Clinical Services Platform for Pharmacies

Category creating solution gives community and advanced practice pharmacists the clinical workflow, EHR integration, and billing infrastructure needed to fully exercise their prescriptive authority — closing the gap between legal authority and real-world practice. [PR.com]

Posted on: 14 May 2026 | 4:29 pm

Mediprocity and SuiteRx Announce Secure Messaging Integration Into Pharmacy Management Software

Mediprocity is excited to announce a partnership with SuiteRx. Mediprocity’s secure messaging tool is now available through a seamless integration into SuiteRx pharmacy management software. The integration promises robust, instant, HIPAA-secure collaboration that streamlines workflows for pharmacies and the facilities and providers they service. Using slow, outdated technology in LTC - leaving voicemails, waiting [PR.com]

Posted on: 14 May 2026 | 1:11 pm

Langham Logistics Opens Largest Pharmaceutical Cooler in the US

Central Indiana is now home to the largest pharma-grade 2°–8°C cooler environment in the United States. [PR.com]

Posted on: 4 May 2026 | 5:04 pm

Parvus Therapeutics Initiates First-in-Human Clinical Trial of PVT401 for Inflammatory Bowel Disease

PVT401, a peptide-MHC nanomedicine, is the second Parvus drug candidate to enter clinical trials. [PR.com]

Posted on: 30 April 2026 | 3:38 pm

Last Chance for Global Pharma to Tap China’s Fast-Growing FDF Market at PHARMCHINA This May

PHARMCHINA 2026 (May 13–15, Shanghai) brings 2,000+ exhibitors together as a key gateway to China’s fast‑growing FDF market, offering global pharma firms critical sourcing, partnering, and regulatory insights before mid‑year decisions close. [PR.com]

Posted on: 28 April 2026 | 10:50 am

Curvo Unveils New Brand Following Integration with BroadJump, Advancing Healthcare Supply Chain Tech

Unified company introduces evolved identity and expanded capabilities to help providers and suppliers make fair, fact-based decisions. [PR.com]

Posted on: 21 April 2026 | 2:00 am

Radiopharmaceutical Manufacturers and Theranostics Alliance (RMTA) Advances Federal Policy in Radiopharmaceuticals and Theranostics

New Division of NEMA Focused on Strengthening Personalized Care for Patients [PR.com]

Posted on: 14 April 2026 | 2:47 pm

Alera Bio Announces Exclusive Licensing Agreement with BLA Technology to Expand Thyroid Hormone Intellectual Property Portfolio

Alera Bio has secured an exclusive global license from BLA Technology, LLC for thyroid hormone-related IP, strengthening its platform for MCT-8 deficiency. The deal expands Alera’s ability to target both neurological and systemic disease drivers, supports its lead program AB-101, reduces development risk, and enables future pipeline growth. [PR.com]

Posted on: 9 April 2026 | 2:00 am